TNF-related apoptosis inducing ligand (TRAIL) and its receptors in tumor surveillance and cancer therapy

被引：147

作者：

Wajant, H ^{[1
]}

Pfizenmaier, K ^{[1
]}

Scheurich, P ^{[1
]}

机构：

[1] Univ Stuttgart, Inst Cell Biol & Immunol, D-70569 Stuttgart, Germany

来源：

APOPTOSIS | 2002年 / 7卷 / 05期

关键词：

apoptosis; cancer; cell death; TRAIL; TRAIL-R1; TRAIL-R2;

D O I：

10.1023/A:1020039225764

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

TNF-related apoptosis-inducing ligand (TRAIL/APO-2L) is a typical member of the TNF ligand family that induces apoptosis by activating the death receptors TRAIL-R1 and TRAIL-R2. TRAIL has attracted great attention in recent years as a promising anti cancer reagent because recombinant soluble TRAIL derivatives induce apoptosis in a broad range of tumor cells but not or only rarely in non-transformed cells. In this review we will address the putative role of TRAIL in cancer treatment in the light of the emerging importance of TRAIL in tumor surveillance and discuss the molecular basis of the cooperation of TRAIL and chemotherapeutic drugs. In particular, we debate controversial data in the literature concerning the cytotoxicity of different TRAIL derivatives on primary human cells.

引用

收藏

页码：449 / 459

页数：11

相关论文

共 135 条

[1] Retinoic acid-induced apoptosis in leukemia cells is mediated by paracrine action of tumor-selective death ligand TRAIL [J].

Altucci, L ;

Rossin, A ;

Raffelsberger, W ;

Reitmair, A ;

Chomienne, C ;

Gronemeyer, H .

NATURE MEDICINE, 2001, 7 (06) :680-686

[2] Caspase-mediated cleavage of hematopoietic progenitor kinase 1 (HPK1) converts an activator of NFκB into an inhibitor of NFκB [J].

Arnold, R ;

Liou, J ;

Drexler, HCA ;

Weiss, A ;

Kiefer, F .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (18) :14675-14684

[3] Apoptosis control by death and decoy receptors [J].

Ashkenazi, A ;

Dixit, VM .

CURRENT OPINION IN CELL BIOLOGY, 1999, 11 (02) :255-260

[4] Disruption of NF-κB signaling reveals a novel role for NF-κB in the regulation of TNF-related apoptosis-inducing ligand expression [J].

Baetu, TM ;

Kwon, H ;

Sharma, S ;

Grandvaux, N ;

Hiscott, J .

JOURNAL OF IMMUNOLOGY, 2001, 167 (06) :3164-3173

[5] p53 upregulates cFLIP, inhibits transcription of NF-κB-regulated genes and induces caspase-8-independent cell death in DLD-1 cells [J].

Bartke, T ;

Siegmund, D ;

Peters, N ;

Reichwein, M ;

Henkler, F ;

Scheurich, P ;

Wajant, H .

ONCOGENE, 2001, 20 (05) :571-580

[6] Sensitization of resistant lymphoma cells to irradiation-induced apoptosis by the death ligand TRAIL [J].

Belka, C ;

Schmid, B ;

Marini, P ;

Durand, E ;

Rudner, J ;

Faltin, H ;

Bamberg, M ;

Schulze-Osthoff, K ;

Budach, W .

ONCOGENE, 2001, 20 (17) :2190-2196

[7] Differential effects of phosphatidylinositol-3/Akt-kinase inhibition on apoptotic sensitization to cytokines in LNCaP and PC-3 prostate cancer cells [J].

Beresford, SA ;

Davies, MA ;

Gallick, GE ;

Donato, NJ .

JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2001, 21 (05) :313-322

[8] Rel/NF-κB transcription factors protect against tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by up-regulating the TRAIL decoy receptor DcR1 [J].

Bernard, D ;

Quatannens, B ;

Vandenbunder, B ;

Abbadie, C .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (29) :27322-27328

[9] TRAIL receptor-2 signals apoptosis through FADD and caspase-8 [J].

Bodmer, JL ;

Holler, N ;

Reynard, S ;

Vinciguerra, P ;

Schneider, P ;

Juo, P ;

Blenis, J ;

Tschopp, J .

NATURE CELL BIOLOGY, 2000, 2 (04) :241-243

[10] Cysteine 230 is essential for the structure and activity of the cytotoxic ligand TRAIL [J].

Bodmer, JL ;

Meier, P ;

Tschopp, J ;

Schneider, P .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (27) :20632-20637

← 1 2 3 4 5 6 7 8 9 10 →